It is remarkable how childhood memories can shape a person’s life. For physics professor and national broadcaster, Dr. Rashad Richey, as a teenager the memory of his grandmother’s struggle with memory loss became a profound influence.
“Watching her struggle with her memory and awareness was deeply impactful to me,” Richey recalls. “She was always a beautiful soul. Seeing her present in the flesh but absent in awareness broke my heart. I never accepted that nothing could be done”.
This experience led Dr. Richey to neuroscience and quantum physics, with a research specialization in experimental physics, neurophysics, photobiomodulation, phonons, and quantum-based biomedical technologies. Today, his groundbreaking invention, the quantum-enhanced Neurological Brain Entrainment Device (NBED), featured in Tech Times, MediTech, and International Business Times, may be the leading technology in the fight against cognitive decline, signaling a chance for millions affected by neurological disorders, particularly Alzheimer’s.
The NBED, which also has a quantum-enhanced version of the device, utilizes a specific combination of subtle bone induction vibrational oscillations, nanocrystal/crystalline technology, and sound and light frequencies at various ranges, with the primary sound frequency of 40 Hz, enters clinical trials in a few months, and it carries with it the weight of countless stories like Richey’s grandmother—stories of loved ones lost in the fog of neurological decline. It also provides hope that the world might finally turn the tide against one of humanity’s most devastating conditions through research. In many circles, this approach to therapeutic healing is known as quantum-medicine, applying knowledge of advanced physics to develop quantum-based biomedical technologies.
Pioneering Quantum Physics Theories
Dr. Rashad Richey’s academic endeavors are marked by multiple peer-reviewed publications and his potential discovery of a new phase of quantum matter that he calls vibraresonant-waves, which he says can emerge from interactions between phonons, lattice structures, and specific stimuli. Phonons are traditionally understood as quanta of energy in crystal lattice vibrations, but Dr. Richey says emergent properties discovered in experimental settings suggest a newly discovered quantum phase property, best described as vibraresonant-waves. Based on discoveries from a quantum mechanics based biomedical technology case study, researching various therapeutic applications, evidence supporting the theoretical view that phonons are not only quasiparticles confined in the space of lattice structures but can become catalysts in the emergence of a distinct phase of quantum matter, akin to photons due to their capacity to generate a field and interact with frequencies from various sources, among other unique behaviors, emerged.The notion that this newly discovered phase of matter potentially exhibits frequency-dependent and field-generating behaviors extends beyond the traditional phononic association. Dr. Richey developed the Quantum Emergent-Lattice Vibration Theory, called Emergent-Lattice Theory (ELT) for short, to explain the phenomena. His peer-reviewed research on the topic is scheduled to be published in the first quarter of 2025.
Furthering his quantum breakthroughs, on November 22nd, 2024, as the invited lecturer in the Physics & Physics Engineering Department at Morgan State University in Washington, Professor Richey provided an interactive demonstration of these vibraresonant-waves with the student attendees, proving wireless energy transfer based via a wide range of frequency-dependent integrations. On December 14th, 2024, at Rolling Out’s annual Peace & Purpose Conference on the campus of Morehouse College, Dr. Richey and Dr. Patricia Washington, an Oriental medical doctor who teaches integrative health sciences to medical students, made a joint presentation, demonstrating in front of a live audience the interactive capabilities and frequency response capacities of vibraresonant-waves. The demonstration sent waves of excitement through the live and virtual audiences, providing irrefutable proof and highlighting the uniqueness of this occurrence.
Dr. Rashad Richey’s Breakthrough Invention, the NBED
The NBED device is a first-of-its-kind medical device designed by Dr. Richey to enhance cognitive health and potentially reverse symptoms of neurological conditions such as Alzheimer’s. His development team meets weekly and includes notable scientists like Dr. Willie Rockward—a nationally noted physicist, physics professor, and Chair of the Physics & Physics Engineering Department at Morgan State University. Also on the team is highly regarded practitioner, Dr. Winston Carhee, Chief Administrator for the West Cascade Medical Center, a brain injury recovery facility with access to neurologists, chiropractors, and specialized healthcare experts. “What Dr. Richey is attempting to accomplish intersects so many sciences that having an American physicist, French research scientist, a chiropractor specializing in brain and spinal care, coupled with the medical center’s resources and neurosurgeon, simply made sense”, said Dr. Carhee in a recent interview with Tech Times.
The NBED aims to enhance cognitive abilities, mental clarity, and memory recall using sound frequencies, nanocrystal technology, photonics, phononic applications, and vibroacoustic stimulations. Studies from MIT and other research institutions have shown that by delivering a unique pattern of frequencies to the brain through sound and light modalities, dormant or suppressed brain functionality can become stimulated again, offering a non-invasive, non-pharmacological method of neurological treatment.
The United States Patent & Trademark Office granted Dr. Richey provisional patent status for the NBED device.
Preliminary case studies have shown promising results, with one notable case involving a 73-year-old woman diagnosed with Alzheimer’s disease. After using the NBED prototype, she experienced notable improvement in cognitive function. The case study participant’s blood pressure decreased from 144 over 125 to 109 over 77 within 5 days. The respondent’s blood sugar levels declined from 8.6 to 6.4 after the case study therapy sessions. Her phosphorylated at threonine (P-TAU) levels—a biomarker associated with Alzheimer’s—seemingly reversed, which was once thought impossible in diagnosed Alzheimer’s patients. MIT’s research findings also aligned with P-TAU being reversible but in lab mice with the disease. Dr. Richey and his team are potentially the first researchers to provide a medically-certified case study report and peer-reviewed publication, showing an Alzheimer’s reversal in a human being. These early findings suggest that the NBED could be a groundbreaking tool in the fight against neurological disorders.
The Science Behind the NBED
The NBED is based on the principle of quantum coherence and brainwave entrainment, a phenomenon where the brain’s electrical oscillations synchronize with external rhythmic stimuli such as flickering lights, sounds, or tactile sensations.
This concept, first identified by Dutch physicist Christiaan Huygens in 1665, has been shown to correlate with various cognitive functions, including perception, memory, and emotional responses.
The NBED induces specific brainwave frequencies to achieve desired mental states and enhance cognitive performance. Dr. Rashad Richey theorizes that brainwave entrainment is linked to both physiological and energetic principles. His quantum physics and neuroscience research have been instrumental in developing the device. It explores the functional role of neural oscillations and their potential to modulate cognitive functions. As theorized by multiple experts, brainwave entrainment principles enable the NBED to create targeted interventions to treat neurological conditions and improve brain health.
Potential Impact on Alzheimer’s and Cognitive Health
Alzheimer’s disease is a devastating neurodegenerative disorder that affects millions of people worldwide. Currently, it has no known cure. If clinical trials confirm its efficacy, the device could become a groundbreaking tool for treating Alzheimer’s.
Beyond Alzheimer’s, the NBED can potentially enhance cognitive functions such as memory, attention, and creativity. This could have far-reaching implications for individuals seeking to optimize their mental performance and for those dealing with cognitive impairments resulting from various neurological conditions or age-related decline. The NBED’s noninvasive nature also offers a promising alternative to traditional drug therapies, changing the space of neurological treatment.
Quantum-Based Biotechnology, Keynote Lectures & Presentations, Higher Education
Many know Dr. Rashad Richey as a successful Emmy-nominated media broadcaster, but his contributions to the scientific community are beginning to eclipse his on-air persona. In addition to his research, discoveries, and inventions, Dr. Richey has delivered keynote addresses and lectures at some of America’s most prestigious organizations and institutions, including being the keynote plenary presenter at the National Society of Black Physicists Annual Conference – 2023. Dr. Richey has been invited to lecture on various disciplines at notable universities, including the University of Michigan, the Physics & Engineering Physics Department at Morgan State University, Morehouse School of Medicine, Clark Atlanta University, the Natural Sciences Department at Albany State University, and Reinhardt University to name a few.
His presentations often focus on the interconnectedness of quantum physics, human cognition, and self-determination, offering audiences a unique perspective on complex topics. Notably, his ability to communicate complex concepts in an accessible and engaging manner has made him a sought-after speaker in academic and industry circles.
Dr. Richey, a rare multidisciplinary scholar, holds multiple advanced degrees, completing doctoral research studies at Clark Atlanta University, a noted HBCU, and earning a Master of Science in Agronomical Physics from the Universite’ de la Renaissance – an institution in academic partnership with the University of Rennes 2, the largest center for higher education research in human sciences and social sciences in western France. His peer-reviewed master’s thesis titled, “Interdisciplinary Analysis of Earth’s Geomagnetic Quantum Field: A Study on Human Physiology & Agronomy“, is published in the International Journal of Science & Research, a double-blind, peer-reviewed academic journal.
Professor Richey additionally holds a Master of Science in Neuroscience from the University of Pacific, completed MBA studies at Beulah Heights University, and earned a Juris Doctor (law degree). He serves as the Managing Partner for the Law Office of Richey & Wilson in Washington, D.C., also known as The Fairness Firm, a multinational law firm. The firm is innovative, employing both attorney and non-attorney experts to provide nuanced advocacy for clients.
Dr. Richey, who routinely engages in higher education studies at multiple institutions simultaneously, is currently preparing to defend his PhD in Quantum Physics research studies at the Paris Graduate School, a research-based institution registered with the French Ministry of Education, approved by the Bureau de Certification International and Qualiopi — a mandatory quality standard accreditation created by the new public institution “France Competencies,” harmonizing the practice and quality of training institutions in France. Dr. Richey is dually enrolled in the doctoral research program in Neurophysics & Quantum Mechanics at the IIC University of Technology and was recently accepted into a highly competitive master’s of science program at Dartmouth College, one of the eight Ivy League institutions in America. Professor Richey is a noted champion of integrative higher education methodologies and collaborative international research modalities to enhance research outcomes.
Future Directions and Research Opportunities
New technologies and research findings emerge steadily in brainwave entrainment, and Dr. Rashad Richey’s work on the NBED opens up numerous opportunities for further investigation and collaboration. Future research could explore the optimal frequencies and stimulation protocols for specific neurological conditions and the long-term effects of brainwave entrainment on cognitive health.
Furthermore, the future clinical trials of NBED may inspire the development of similar devices and therapies that target a wide range of disorders. Integrating brainwave entrainment with new technologies, such as virtual reality (VR) and personalized medicine, could lead to more interventions.
Richey’s work drives further exploration in this exciting field, making way for discoveries that could change the lives of countless individuals affected by neurological conditions. When asked how he fits so much into one day, Dr. Richey answered, “We are more than physical beings and capable of accomplishing feets congruent to our mind’s willingness to learn, explore, experience, serve, and know”.
Truly, Dr. Rashad Richey’s BED and other quantum-based biotechnologies represent a milestone in enhancing cognitive health. Its promising preliminary results will potentially pave a future where neurological conditions can be effectively managed and cognitive health can be fully realized. His work may one day help families avoid the heartbreak he experienced, turning his grandmother’s legacy into a gift of hope for countless others.
